Kaiser profits more than double
Kaiser Permanente has reported that its Kaiser Foundation Health Plan, Kaiser Foundation Hospitals and subsidiaries saw dramatic increases in its net income, operating income and investment income over the last three and nine months, with nine month profits more than doubling. What's particularly noteworthy is that as of a year ago, the company stood to lose billions.
A few choice numbers: Kaiser's operating income more than doubled, from $868 million in the first three quarters of 2006 to $1.8 billion this year, and net income for the first nine months shot up from $1.1 billion to $2.5 billion. Net income climbed a staggering 56.8 percent in the third quarter, from $417 million last year to $654 million for this year. All of this can't be attributed to a growth in membership among the health plans, which was more or less level at 8.7 million beneficiaries. Instead, Kaiser attributes the big margins to health care cost cutting and administrative efficiencies.
Given that Kaiser's a non-profit organization, these results are sure to raise some eyebrows. I don't know about you, but if I were a Kaiser exec, I'd see these results as a bit of a liability in a climate where non-profits are facing losses of tax exemptions. Kaiser, wouldn't it have made sense to release a report documenting your good works given these big numbers? Or do you really prefer to have a big bullseye painted on your side?
To learn more about Kaiser's numbers:
- read this San Francisco Business Journal piece
Related Articles:
Kaiser faces patient dumping charges. Report
Kaiser fined $2 million for transplant problems. Article
Kaiser employee blows whistle on potential $7B loss. Article
Kaiser controversy fells top exec. Article
Kaiser fined $2 million for transplant problems. Article
Kaiser avoids Medicare funding loss. Article
Comments
That is a huge increase in profit for Kaiser. Unless they are fudging numbers, it is unlikely that the huge increase in revenues is due to the impact of multimillion dollar IT infrastructure investment. If so, the Feds need to look at loopholes that might be exploited by Health IT tools! This story merits in depth review..
Post new comment
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies




